Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.390
-0.010 (-0.71%)
At close: Apr 28, 2026, 4:00 PM EDT
1.350
-0.040 (-2.88%)
After-hours: Apr 28, 2026, 7:32 PM EDT
Cocrystal Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cost of Revenue | 5.06 | 12.54 | 15.17 | 12.39 | 8.79 | |
| Gross Profit | -5.06 | -12.54 | -15.17 | -12.39 | -8.79 | |
| Selling, General & Admin | 3.96 | 5.34 | 5.99 | 5.75 | 5.43 | |
| Operating Expenses | 3.96 | 5.34 | 5.99 | 5.75 | 5.43 | |
| Operating Income | -9.02 | -17.88 | -21.16 | -18.14 | -14.22 | |
| Interest Expense | - | - | - | -0 | -0 | |
| Interest & Investment Income | 0.13 | 0.54 | 0.64 | - | - | |
| Currency Exchange Gain (Loss) | 0.05 | -0.16 | -0.07 | -0.02 | -0.01 | |
| Other Non Operating Income (Expenses) | - | - | - | 0.01 | 0.05 | |
| EBT Excluding Unusual Items | -8.83 | -17.5 | -20.58 | -18.15 | -14.19 | |
| Impairment of Goodwill | - | - | - | -19.09 | - | |
| Legal Settlements | - | - | 2.6 | -1.6 | - | |
| Pretax Income | -8.83 | -17.5 | -17.98 | -38.84 | -14.19 | |
| Net Income | -8.83 | -17.5 | -17.98 | -38.84 | -14.19 | |
| Net Income to Common | -8.83 | -17.5 | -17.98 | -38.84 | -14.19 | |
| Shares Outstanding (Basic) | 11 | 10 | 10 | 8 | 7 | |
| Shares Outstanding (Diluted) | 11 | 10 | 10 | 8 | 7 | |
| Shares Change (YoY) | 10.97% | 5.42% | 18.52% | 10.58% | 60.04% | |
| EPS (Basic) | -0.78 | -1.72 | -1.86 | -4.77 | -1.93 | |
| EPS (Diluted) | -0.78 | -1.72 | -1.86 | -4.77 | -1.93 | |
| Free Cash Flow | -8.2 | -16.49 | -14.78 | -21.51 | -12.77 | |
| Free Cash Flow Per Share | -0.73 | -1.62 | -1.53 | -2.64 | -1.73 | |
| EBITDA | -8.95 | -17.75 | -20.97 | -17.95 | -14.03 | |
| D&A For EBITDA | 0.07 | 0.13 | 0.19 | 0.19 | 0.19 | |
| EBIT | -9.02 | -17.88 | -21.16 | -18.14 | -14.22 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.